This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Brian N Swanson: Innovator in Allergy Treatment
Introduction
Brian N Swanson is a notable inventor based in Paris, France. He has made significant contributions to the field of allergy treatment through his innovative research and development. His work focuses on methods for preventing and treating allergies, which has the potential to improve the quality of life for many individuals suffering from allergic conditions.
Latest Patents
Brian N Swanson holds a patent for "Methods for preventing or treating allergy by administering an IL-4R antagonist." This invention provides methods for preventing or treating allergies and includes approaches for reducing susceptibility to allergens in subjects with conditions such as atopic dermatitis, asthma, allergic rhinitis, and eosinophilic esophagitis. The methods involve administering a pharmaceutical composition that includes an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody. He has 1 patent to his name.
Career Highlights
Throughout his career, Brian has worked with prominent companies in the biotechnology and pharmaceutical sectors. Notably, he has been associated with Sanofi Biotechnology and Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in allergy treatments.
Collaborations
Brian N Swanson has collaborated with various professionals in his field, including his coworker Jennifer D Hamilton. These collaborations have fostered innovation and have been instrumental in advancing research in allergy treatment.
Conclusion
Brian N Swanson is a distinguished inventor whose work in allergy treatment has the potential to make a significant impact on public health. His innovative methods and collaborations highlight his commitment to improving the lives of those affected by allergies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile